Evaluation of CA125 and NT-proBNP values in patients undergoing ...
www.ncbi.nlm.nih.gov › PMC4394323
The objective of this study is to evaluate the impact of TAVI on carbohydrate antigen 125 (CA125) and N-Terminal pro Brain-type Natriuretic Peptide (NT-proBNP) ...
Objectives: The aim of this study was to evaluate the serum levels of carbohydrate antigen 125 (CA125) in patients with congestive heart failure (CHF).
Missing: Antonini- Canterin aortic stenosis
This study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for ...
Oct 5, 2022 · Elevated-CA125 implicates poorer short- and long-term prognosis in LVA patients undergoing SLVR.
People also ask
What is carbohydrate antigen 125 a marker of?
What is carbohydrate antigen 125 in heart failure?
What is the normal range for carbohydrate antigen 125?
What is CA-125 in heart failure?
Feb 2, 2024 · Carbohydrate antigen 125 (CA125), a biomarker associated with fluid overload, has proven useful in managing diuretic therapy in heart failure.
People also search for
Related conditions
For informational purposes only. Consult your local medical authority for advice.
Dec 31, 2018 · Carbohydrate antigen 125 (CA-125) is an emerging prognostic biomarker for heart failure. We aimed to test the long-term prognostic value of ...
Missing: valve | Show results with:valve
Patients with HF had a much higher serum level of CA125 than healthy controls (Table 2). In a study of 529 patients with AHF, the average plasma level of CA125 ...
Antonini-Canterin F, Popescu BA, Popescu AC, et al. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate ...
Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.
Jun 28, 2020 · CA-125, a tumor biomarker, outperformed frailty for predicting the primary endpoint within the first year after TAVR.